Acorda Therapeutics Joins Russell 3000 Index

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics (Nasdaq: ACOR) was added to the broad-market Russell 3000® Index on June 22, 2007. A listing of all members can be found at Annual reconstitution of Russell’s U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. The Russell 3000 serves as the U.S. component to the Russell Global Index, which Russell launched earlier this year to offer investors a comprehensive set of equity benchmarks that cover world-wide investing opportunities. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies.

Back to news